Eli Lilly (LLY) reports qtrly profits (EPS) and revenues:

• Reported: $6.31 vs. $3.92 = +61%
• Estimates: $5.52 vs. $3.92 = +41%
• Beat the street by $0.79
• Revenue: +38%
• Revenue Est: +27%

Eli Lilly (LLY) reports qtrly profits (EPS) and revenues:

• Reported: $3.34 vs. $2.58 = +29%
• Estimates: $4.64 vs. $2.58 = +80%
• Missed the street by $1.30
• Revenue: +45%
• Revenue Est: +50%

Eli Lilly (LLY) reports qtrly profits (EPS) and revenues:

• Reported: $5.32 vs. $2.49 = +114%
• Estimates: $5.45 vs. $2.49 = +119%
• Missed the street by $0.13
• Revenue: +45%
• Revenue Est: +50%

Eli Lilly (LLY) reports qtrly profits (EPS) and revenues:

• Reported: $1.18 vs. $0.10 = +1080%
• Estimates: $4.48 vs. $0.10 = +4380%
• Missed the street by $3.30
• Revenue: +20%
• Revenue Est: +29%

Eli Lilly (LLY) reports qtrly profits (EPS) and revenues:

• Reported: $3.92 vs. $2.11 = +86%
• Estimates: $2.75 vs. $2.11 = +30%
• Beat the street by $1.17
• Revenue: +36%
• Revenue Est: +20%

Eli Lilly (LLY) reports qtrly profits (EPS) and revenues:

• Reported: $2.58 vs. $1.62 = +59%
• Estimates: $2.51 vs. $1.62 = +55%
• Beat the street by $0.07
• Revenue: +26%
• Revenue Est: +29%

Eli Lilly (LLY) reports qtrly profits (EPS) and revenues:

• Reported: $2.49 vs. $2.09 = +19%
• Estimates: $2.79 vs. $2.09 = +33%
• Missed the street by $0.30
• Revenue: +28%
• Revenue Est: +22%

Eli Lilly (LLY) reports qtrly profits (EPS) and revenues:

• Reported: $0.10 vs. $1.98 = -95%
• Estimates: $2.97 vs. $1.98 = +50%
• Missed the street by $2.87
• Revenue: +37%
• Revenue Est: +28%

Eli Lilly (LLY) reports qtrly profits (EPS) and revenues:

• Reported: $2.11 vs. $1.25 = +69%
• Estimates: $2.00 vs. $1.25 = +60%
• Beat the street by $0.11
• Revenue: +28%
• Revenue Est: +16%

Eli Lilly (LLY) reports qtrly profits (EPS) and revenues:

• Reported: $1.62 vs. $2.77 = -42%
• Estimates: $1.80 vs. $2.77 = -35%
• Missed the street by $0.18
• Revenue: -11%
• Revenue Est: -13%